META:NASDAQMeta Platforms, Inc. Analysis
Data as of 2026-09-04 - not real-time
$616.77
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Meta Platforms, Inc. trades at $616.77, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has gained 3.6% over the past 30 days. Momentum indicators put RSI at 62.4 (approaching overbought) with MACD reading bullish. Watch $537.27 as support and $619.46 as the nearer resistance level.
The shares look overvalued, trading on 23.2 times earnings above a sector average of 15.5. Sell-side targets cluster 22.4% above the current quote. Revenue is growing at 28.0% on a 29.8% profit margin. The 0.34% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 41.5%, a beta of 1.41 and a maximum drawdown of 32.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
The shares look overvalued, trading on 23.2 times earnings above a sector average of 15.5. Sell-side targets cluster 22.4% above the current quote. Revenue is growing at 28.0% on a 29.8% profit margin. The 0.34% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 8 — high. With 30-day volatility of 41.5%, a beta of 1.41 and a maximum drawdown of 32.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.
Top Market Events
Meta Platforms stock is trading higher after a new AI launch and a legal settlement.Washington's proposed Carolina Principles could reduce regulatory friction as Meta targets $130 billion to $145 billion...Meta Platforms stock is trading higher as investors weigh a multibillion-dollar teen-safety settleme
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 622.29
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 23.2 versus sector average of 15.5
- Trading below the 200-day average of 622.29
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 23.2 versus sector average of 15.5
- Analyst targets imply +22.4% versus the current price
- Profit margin of 29.8% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth28.00%
Profit Margin29.83%
P/E Ratio23.2
ROE29.85%
ROA14.59%
Debt/Equity43.00
P/B Ratio6.0
Op. Cash Flow$130.3B
Free Cash Flow$21.6B
Industry P/E15.5
Technical Analysis
TrendBearish
RSI62.4
Support$537.27
Resistance$619.46
MA 20$576.88
MA 50$595.49
MA 200$622.29
MACDBullish
VolumeStable
Fear & Greed Index95.48
Valuation
Fair Value$283.28
Target Price$754.77
Upside/Downside22.38%
GradeOvervalued
TypeGrowth
Dividend Yield0.34%
Risk Assessment
Beta1.41
Volatility41.49%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.